Powered by HealthTechMovers.com
We added 5 stocks to our Healthcare & Biotech Stock Watchlist today because they are receiving Bullish Sentiment from investors and financial bloggers.
In addition, they are generating positive media buzz and/or have insider trading signals which came to our attention. This list below is subject to change on a daily basis, so please be sure you subscribe to our email newsletter.
UnitedHealth, UNH
Summary: UnitedHealth Group, Inc. provides a wide range of health care products and services, such as health maintenance organizations, point of service plans, preferred provider organizations and managed fee-for-service programs. UnitedHealth has the most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. The company has acquired a number of competing healthcare which transformed it from a pure health insurer to a comprehensive healthcare provider. UnitedHealth reports through two segments: UnitedHealthcare and Optum. UnitedHealthcareis divided into UnitedHealthcare Employer & Individual; UnitedHealthcare Medicare & Retirement; UnitedHealthcare Community & State and UnitedHealthcare Global; providing health care benefits globally. Optum is a technology-enabled health services business serving the broad health care marketplace, including those who need care. The segment is divided into OptumHealth, OptumInsight, OptumRx and Optum eliminations.
- Last Price: $480.62
- Price Change: $1.80, 0.38%
- Yearly Gain: -1.39%
- Market Cap: $445.80B
- P/E Ratio: 21.898
Here are 3rd party ratings for UNH:
- TipRanks.com: Strong Buy
- TradingView.com: Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Bottom 27% (184 out of 251)
What is the sentiment on the street regarding UnitedHealth ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Bullish
- Blogger Consensus: Bullish
- Media Buzz: Medium
- Insider Signal: Neutral
- Investor Sentiment: Positive
- Hedge Fund signal: Very Positive
If you are interested in UNH or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on UNH before you decide to make any investment.
Click here for chart >>
Apellis Pharmaceuticals, APLS
Summary: Apellis Pharmaceuticals, Inc. is a clinical-stage biotech focused on the development of novel therapeutics, which work through the inhibition of the complement system, specially targeting the C3 protein of the complement system to treat autoimmune and inflammatory diseases.
- Last Price: $87.48
- Price Change: -$1.38, -1.55%
- Yearly Gain: 98.30%
- Market Cap: $10.35B
- P/E Ratio: -14.155
Here are 3rd party ratings for APLS:
- TipRanks.com: Strong Buy
- TradingView.com: Neutral
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Hold, Top 45% (115 out of 251)
What is the sentiment on the street regarding Apellis Pharmaceuticals ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Bullish
- Blogger Consensus: Bullish
- Media Buzz: Low
- Insider Signal: Positive
- Investor Sentiment: Very Positive
- Hedge Fund signal: Very Positive
If you are interested in APLS or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on APLS before you decide to make any investment.
Click here for chart >>
AbCellera Biologics, ABCL
Summary: AbCellera Biologics Inc. is a technology company which searches, decodes and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera Biologics Inc. is based in Vancouver, Canada.
- Last Price: $6.61
- Price Change: $0.77, 13.18%
- Yearly Gain: -26.07%
- Market Cap: $1.69B
- P/E Ratio: -31.895
Here are 3rd party ratings for ABCL:
- TipRanks.com: Strong Buy
- TradingView.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Top 45% (115 out of 251)
What is the sentiment on the street regarding AbCellera Biologics ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Bullish
- Blogger Consensus: Bullish
- Media Buzz: Low
- Insider Signal: Positive
- Investor Sentiment: Positive
- Hedge Fund signal: Positive
If you are interested in ABCL or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on ABCL before you decide to make any investment.
Click here for chart >>
Tenaya Therapeutics, TNYA
Summary: Tenaya Therapeutics Inc. is a biotechnology company. It discovers, develop and deliver curative therapies which address the underlying causes of heart disease. The company's product platform consist Gene Therapy, Cellular Regeneration and Precision Medicine. Tenaya Therapeutics Inc. is based in SOUTH SAN FRANCISCO, Calif.
- Last Price: $7.44
- Price Change: $0.08, 1.09%
- Yearly Gain: 10.68%
- Market Cap: $492.16M
- P/E Ratio: -2.979
Here are 3rd party ratings for TNYA:
- TipRanks.com: Strong Buy
- TradingView.com: Buy
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Hold, Top 45% (115 out of 251)
What is the sentiment on the street regarding Tenaya Therapeutics ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Bullish
- Blogger Consensus: Bullish
- Media Buzz: Low
- Insider Signal: Positive
- Investor Sentiment: Very Positive
- Hedge Fund signal: Neutral
If you are interested in TNYA or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on TNYA before you decide to make any investment.
Click here for chart >>
Caribou Biosciences, CRBU
Summary: Caribou Biosciences Inc. is a clinical-stage CRISPR genome-editing biopharmaceutical company. It involved in developing a pipeline of genome-edited, off-the-shelf CAR-T and CAR-NK cell therapies for the treatment of both hematologic malignancies and solid tumors. Caribou Biosciences Inc. is based in BERKELEY, Calif.
- Last Price: $4.78
- Price Change: $0.44, 10.14%
- Yearly Gain: -47.58%
- Market Cap: $266.32M
- P/E Ratio: -2.441
Here are 3rd party ratings for CRBU:
- TipRanks.com: Strong Buy
- TradingView.com: Buy
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Hold, Top 45% (115 out of 251)
What is the sentiment on the street regarding Caribou Biosciences ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Bullish
- Blogger Consensus: Bullish
- Media Buzz: Low
- Insider Signal: Positive
- Investor Sentiment: Positive
- Hedge Fund signal: Positive
If you are interested in CRBU or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on CRBU before you decide to make any investment.
Click here for chart >>
Thanks for reading!